1. Home
  2. ADMA vs CADE Comparison

ADMA vs CADE Comparison

Compare ADMA & CADE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • CADE
  • Stock Information
  • Founded
  • ADMA 2004
  • CADE 1876
  • Country
  • ADMA United States
  • CADE United States
  • Employees
  • ADMA N/A
  • CADE N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • CADE Major Banks
  • Sector
  • ADMA Health Care
  • CADE Finance
  • Exchange
  • ADMA Nasdaq
  • CADE Nasdaq
  • Market Cap
  • ADMA 5.1B
  • CADE 5.9B
  • IPO Year
  • ADMA N/A
  • CADE N/A
  • Fundamental
  • Price
  • ADMA $19.97
  • CADE $29.76
  • Analyst Decision
  • ADMA Strong Buy
  • CADE Buy
  • Analyst Count
  • ADMA 4
  • CADE 12
  • Target Price
  • ADMA $24.25
  • CADE $37.08
  • AVG Volume (30 Days)
  • ADMA 3.4M
  • CADE 1.1M
  • Earning Date
  • ADMA 05-07-2025
  • CADE 07-21-2025
  • Dividend Yield
  • ADMA N/A
  • CADE 3.63%
  • EPS Growth
  • ADMA N/A
  • CADE N/A
  • EPS
  • ADMA 0.84
  • CADE 2.85
  • Revenue
  • ADMA $459,381,000.00
  • CADE $1,734,570,000.00
  • Revenue This Year
  • ADMA $19.45
  • CADE $13.43
  • Revenue Next Year
  • ADMA $28.10
  • CADE $10.60
  • P/E Ratio
  • ADMA $23.74
  • CADE $10.63
  • Revenue Growth
  • ADMA 62.23
  • CADE 45.52
  • 52 Week Low
  • ADMA $9.40
  • CADE $25.22
  • 52 Week High
  • ADMA $25.67
  • CADE $40.20
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 46.14
  • CADE 44.42
  • Support Level
  • ADMA $19.28
  • CADE $29.77
  • Resistance Level
  • ADMA $20.14
  • CADE $30.93
  • Average True Range (ATR)
  • ADMA 0.74
  • CADE 0.57
  • MACD
  • ADMA -0.09
  • CADE -0.21
  • Stochastic Oscillator
  • ADMA 55.14
  • CADE 0.00

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

Share on Social Networks: